Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ostrov

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Seminars in Immunology|December 17, 2009
Recognition of additional roles for immunoglobulin domains in immune functionJohn P Cannon, Larry J Dishaw, Robert N Haire, et al.
Molecular Cancer Therapeutics|October 26, 2014
Small molecule inhibitor YM155-mediated activation of death receptor 5 is crucial for chemotherapy-induced apoptosis in pancreatic carcinomaXiangxuan Zhao, William M Puszyk, Zaiming Lu, et al.
Journal of Medicinal Chemistry|January 29, 2013
Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cellsLilibeth A Salvador, Kanchan Taori, Jason S Biggs, et al.
Journal of Medicinal Chemistry|July 21, 2009
Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivoElena V Kurenova, Darell L Hunt, Dihua He, et al.
Breast Cancer Research and Treatment|April 9, 2014
Discovery of structure-based small molecular inhibitor of αB-crystallin against basal-like/triple-negative breast cancer development in vitro and in vivoZhijuan Chen, Qing Ruan, Song Han, et al.
Seminars in Immunology|November 4, 2004
Mechanisms of antigen receptor evolutionDonna D Eason, John P Cannon, Robert N Haire, et al.
Cellular Signalling|October 10, 2006
The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptorMichael D Godeny, Jacqueline Sayyah, Dannielle VonDerLinden, et al.
International Journal of Molecular Sciences|November 14, 2023
Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future TherapeuticsReed L Berkowitz, Andrew P Bluhm, Glenn W Knox, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|June 10, 2008
Crystallization of the focal adhesion kinase targeting (FAT) domain in a primitive orthorhombic space groupAndrew T Magis, Kate M Bailey, Elena V Kurenova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 10, 2001
Immunobiological analysis of TCR single-chain transgenic mice reveals new possibilities for interaction between CDR3alpha and an antigenic peptide bound to MHC class IW Zhang, S Honda, F Wang, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Seminars in Immunology|December 17, 2009
Recognition of additional roles for immunoglobulin domains in immune functionJohn P Cannon, Larry J Dishaw, Robert N Haire, et al.
Molecular Cancer Therapeutics|October 26, 2014
Small molecule inhibitor YM155-mediated activation of death receptor 5 is crucial for chemotherapy-induced apoptosis in pancreatic carcinomaXiangxuan Zhao, William M Puszyk, Zaiming Lu, et al.
Journal of Medicinal Chemistry|January 29, 2013
Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cellsLilibeth A Salvador, Kanchan Taori, Jason S Biggs, et al.
Journal of Medicinal Chemistry|July 21, 2009
Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivoElena V Kurenova, Darell L Hunt, Dihua He, et al.
Breast Cancer Research and Treatment|April 9, 2014
Discovery of structure-based small molecular inhibitor of αB-crystallin against basal-like/triple-negative breast cancer development in vitro and in vivoZhijuan Chen, Qing Ruan, Song Han, et al.
Seminars in Immunology|November 4, 2004
Mechanisms of antigen receptor evolutionDonna D Eason, John P Cannon, Robert N Haire, et al.
Cellular Signalling|October 10, 2006
The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptorMichael D Godeny, Jacqueline Sayyah, Dannielle VonDerLinden, et al.
International Journal of Molecular Sciences|November 14, 2023
Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future TherapeuticsReed L Berkowitz, Andrew P Bluhm, Glenn W Knox, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|June 10, 2008
Crystallization of the focal adhesion kinase targeting (FAT) domain in a primitive orthorhombic space groupAndrew T Magis, Kate M Bailey, Elena V Kurenova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 10, 2001
Immunobiological analysis of TCR single-chain transgenic mice reveals new possibilities for interaction between CDR3alpha and an antigenic peptide bound to MHC class IW Zhang, S Honda, F Wang, et al.
Pageof 12